Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway

LA Price, J Strnad, MH Pausch and JR Hadcock

Cyanamid Agricultural Research Center, Princaton, New Jersey 08543- 0400, USA.

The rat A2a adenosine receptor, a G protein-coupled receptor, was functionally expressed in the yeast Saccharomyces cerevisiae. High affinity binding sites for A2a adenosine agonists were detected in yeast membranes containing the endogenous Grx protein Gpa1. Agonist saturation binding isotherms using [3H]5'-N-ethylcarboxamidoadenosine indicated that the A2a adenosine receptor expressed in yeast cell membranes displays pharmacological properties equivalent to those observed when the receptor is expressed in human embryonic kidney 293 cell membranes. The rank order of potency of various agonists in [3H]5'- N-ethylcarboxamidoadenosine competition binding assays performed with yeast cell membranes was comparable to that seen for the receptor expressed in mammalian cell membranes. Adenosine agonist-dependent growth response of yeast strains expressing the A2a adenosine receptor was elicited via activation of the yeast pheromone-response pathway. Induction of a pheromone-responsive FUS1-HIS3 reporter gene in far1 his3 cells permits cell growth in medium lacking histidine. The sensitivity of the bioassay was increased by deletion of the STE2 gene, which encodes the yeast alpha-mating pheromone receptor. The growth response was dose dependent, and agonists of varying affinities displayed a rank order of potency comparable to that observed in competition binding assays. Agonist-activated growth assays performed in liquid culture gave ED50 values for various adenosine agonists consistent with reported Kd alpha values. Yeast strains expressing a single receptor/G protein complex will be useful as a model system for the study of receptor/G protein interactions in vivo.

Volume 50, Issue 4, pp. 829-837, 10/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. W. Beukers, J. van Oppenraaij, P. P. W. van der Hoorn, C. C. Blad, H. d. Dulk, J. Brouwer, and A. P. IJzerman Random Mutagenesis of the Human Adenosine A2B Receptor Followed by Growth Selection in Yeast. Identification of Constitutively Active and Gain of Function Mutations Mol. Pharmacol., March 1, 2004; 65(3): 702 - 710. [Abstract] [Full Text] [PDF]

				D. H. Floyd, A. Geva, S. P. Bruinsma, M. C. Overton, K. J. Blumer, and T. J. Baranski C5a Receptor Oligomerization: II. FLUORESCENCE RESONANCE ENERGY TRANSFER STUDIES OF A HUMAN G PROTEIN-COUPLED RECEPTOR EXPRESSED IN YEAST J. Biol. Chem., September 12, 2003; 278(37): 35354 - 35361. [Abstract] [Full Text] [PDF]

				C. Schmidt, B. Li, L. Bloodworth, I. Erlenbach, F.-Y. Zeng, and J. Wess Random Mutagenesis of the M3 Muscarinic Acetylcholine Receptor Expressed in Yeast: IDENTIFICATION OF POINT MUTATIONS THAT "SILENCE" A CONSTITUTIVELY ACTIVE MUTANT M3 RECEPTOR AND GREATLY IMPAIR RECEPTOR/G PROTEIN COUPLING J. Biol. Chem., August 8, 2003; 278(32): 30248 - 30260. [Abstract] [Full Text] [PDF]

				A. Sachpatzidis, B. K. Benton, J. P. Manfredi, H. Wang, A. Hamilton, H. G. Dohlman, and E. Lolis Identification of Allosteric Peptide Agonists of CXCR4 J. Biol. Chem., January 3, 2003; 278(2): 896 - 907. [Abstract] [Full Text] [PDF]

				J. J. Miret, L. Rakhilina, L. Silverman, and B. Oehlen Functional Expression of Heteromeric Calcitonin Gene-related Peptide and Adrenomedullin Receptors in Yeast J. Biol. Chem., February 22, 2002; 277(9): 6881 - 6887. [Abstract] [Full Text] [PDF]

				W. Parrish, M. Eilers, W. Ying, and J. B. Konopka The Cytoplasmic End of Transmembrane Domain 3 Regulates the Activity of the Saccharomyces cerevisiae G-Protein-Coupled {alpha}-Factor Receptor Genetics, February 1, 2002; 160(2): 429 - 443. [Abstract] [Full Text] [PDF]

				M. Dosil, K. A. Schandel, E. Gupta, D. D. Jenness, and J. B. Konopka The C Terminus of the Saccharomyces cerevisiae alpha -Factor Receptor Contributes to the Formation of Preactivation Complexes with Its Cognate G Protein Mol. Cell. Biol., July 15, 2000; 20(14): 5321 - 5329. [Abstract] [Full Text]

				T. J. Baranski, P. Herzmark, O. Lichtarge, B. O. Gerber, J. Trueheart, E. C. Meng, T. Iiri, S. P. Sheikh, and H. R. Bourne C5a Receptor Activation. GENETIC IDENTIFICATION OF CRITICAL RESIDUES IN FOUR TRANSMEMBRANE HELICES J. Biol. Chem., May 28, 1999; 274(22): 15757 - 15765. [Abstract] [Full Text] [PDF]

				M. Dosil, L. Giot, C. Davis, and J. B. Konopka Dominant-Negative Mutations in the G-Protein-Coupled alpha -Factor Receptor Map to the Extracellular Ends of the Transmembrane Segments Mol. Cell. Biol., October 1, 1998; 18(10): 5981 - 5991. [Abstract] [Full Text]

				J. R. Erickson, J. J. Wu, J. G. Goddard, G. Tigyi, K. Kawanishi, L. D. Tomei, and M. C. Kiefer Edg-2/Vzg-1 Couples to the Yeast Pheromone Response Pathway Selectively in Response to Lysophosphatidic Acid J. Biol. Chem., January 16, 1998; 273(3): 1506 - 1510. [Abstract] [Full Text] [PDF]

				K. Gillen, M Pausch, and H. Dohlman N-terminal domain of Gpa1 (G protein alpha) subunit) is sufficient for plasma membrane targeting in yeast Saccharomyces cerevisiae J. Cell Sci., January 11, 1998; 111(21): 3235 - 3244. [Abstract] [PDF]

				A. Geva, T. B. Lassere, O. Lichtarge, S. K. Pollitt, and T. J. Baranski Genetic Mapping of the Human C5a Receptor. IDENTIFICATION OF TRANSMEMBRANE AMINO ACIDS CRITICAL FOR RECEPTOR FUNCTION J. Biol. Chem., November 3, 2000; 275(45): 35393 - 35401. [Abstract] [Full Text] [PDF]

				I. Erlenbach, E. Kostenis, C. Schmidt, C. S.-L. Gal, D. Raufaste, M. E. Dumont, M. H. Pausch, and J. Wess Single Amino Acid Substitutions and Deletions That Alter the G Protein Coupling Properties of the V2 Vasopressin Receptor Identified in Yeast by Receptor Random Mutagenesis J. Biol. Chem., July 27, 2001; 276(31): 29382 - 29392. [Abstract] [Full Text] [PDF]